Commitments and Contingencies (Details) - Koronis Biomedical Corporation [Member]		12 Months Ended
	Aug. 05, 2021 USD ($) Installment	Dec. 31, 2021 USD ($)	Jun. 30, 2022 USD ($)
Commitments and Contingencies [Abstract]
Amount of grant approval received	$ 1,700,000
Non-refundable technology license fee	$ 428,160
Number of equal monthly installments | Installment	12
Research and Development Expense [Member]
Commitments and Contingencies [Abstract]
Non-refundable technology license fee expenses		$ 428,160
Current Accounts Payable [Member]
Commitments and Contingencies [Abstract]
Non-refundable technology license fee			$ 392,480